Quick search:
| Result | Content | Outlet | Published | Research |
|---|---|---|---|---|
| Result | Content | Outlet | Published | Research |
| 1 | Outlining Successful Steps for Scale-Up and BLA Filings | BioPharm International | 9 days ago |
|
| 2 | FDA Accepts BLA for Omidubicel for Individuals Who Need Bone Marrow Transplants | Pharmacy Times | 6 days ago |
|
| 3 | FDA Accepts for Review Fresenius Kabi’s BLA for Tocilizumab Biosimilar | JD Supra | 7 days ago |
|
| 4 | ImmunityBio’s Bladder Cancer Immunotherapy BLA gets FDA Nod | BioSpace | 12 days ago |
|
| 5 | Biopharma Co. Planning BLA for DMD Drug Research Report | Streetwise Reports | 5 days ago |
|
| 6 | Iovance (IOVA) Q2 Earnings Miss, Lifileucel BLA on Track | Nasdaq | 5 days ago |
|
| 7 | Middleburg BLA Opponents Challenge Council | Loudoun Now | 7 days ago |
|
| 8 | FDA Committee Will Meet Next Month for Potential RBX2660 Approval | Contagionlive.com | 15 hours ago |
|
| 9 | FDA accepts BLA for Sandoz's proposed biosimilar natalizumab | Pharmaceutical Technology | 15 days ago |
|
| 10 | FDA Defers Action on BLA for Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma | OncLive | 27 days ago |
|
| 11 | 2 die in stone quarry collapse in Bla Baramulla | The Northlines | 12 hours ago |
|
| 12 | Citius Pharmaceuticals, Inc. Holds Pre-BLA Meeting with the FDA for I/ONTAK (denileukin diftitox) for the Treatment of Cutaneous T-Cell Lymphoma | PR Newswire | 29 days ago |
|
| 13 | Zai Lab Announces Acceptance by China’s NMPA of the BLA for Efgartigimod for Patients with Generalized Myasthenia Gravis | Yahoo Finance | 28 days ago |
|
| 14 | Some premier college athletes face option to exchange NIL riches for portion of future earnings | CBS Sports | 9 days ago |
|
| 15 | FDA Accepts BLA for Trastuzumab Duocarmazine for Advanced HER2+ Breast Cancer | OncLive | 29 days ago |
|
| 16 | FDA Accepts BLA for Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer | Targeted Oncology | 16 days ago |
|
| 17 | FDA Issues NDA And BLA Recommendations Warranting Real-Time Oncology Review | Food and Drugs Law | 14 days ago |
|
| 18 | Made in Chelsea's Jamie Laing shows off incredible body transformation after weight loss | The Mirror | 14 hours ago |
|
| 19 | Atara Biotherapeutics Announces Second Quarter 2022 Financial Results and Corporate Strategy Update | Yahoo Finance | 1 day ago |
|
| 20 | 'BLA militants' kill kidnapped Pakistani army officer, friend | TRT World | 26 days ago |
|
| 21 | Alvotech board expansion, [vic-]trastuzumab duocarmazine BLA accepted, second Zylonta® + rituximab DLBCL trials, Polpharma natalizumab MAA and eight-year Perjeta® data | Lexology | 23 days ago |
|
| 22 | Zai Lab Announces Second Quarter 2022 Financial Results and Corporate Updates | GlobeNewswire | 12 hours ago |
|
| 23 | featuring Xbrane's ranibizumab BLA, Viatris' insulin glargine, Alvotech's aflibercept study and AU's July PBAC meeting | Lexology | 1 month ago |
|
| 24 | BLA targets vehicle of oil firm, warns against exploration in Balochistan | News Vibes of India | 14 days ago |
|
| 25 | REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II | PR Newswire | 7 days ago |
|
| 26 | Revance Reports Second Quarter 2022 Financial Results, Provides Corporate Update | Yahoo Finance | 12 hours ago |
|
| 27 | Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries | Nature.com | 6 days ago |
|
| 28 | How the West is Liened: A comparison of builders lien legislation in British Columbia and Alberta | Dentons | 16 hours ago |
|
| 29 | bluebird bio Reports Second Quarter 2022 Financial Results and Highlights Operational Progress | Business Wire | 5 days ago |
|
| 30 | Jamie Laing and celebrity 'twin' Judge Rinder show off ripped body transformations to impressed fans | Manchester Evening News | 17 hours ago |
|
| 31 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TG Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline | TGTX | 1 day ago |
|
| 32 | Pakistan: 'Death Squads' Under Attack In Balochistan – Analysis | Eurasia Review | 23 hours ago |
|
| 33 | OMEROS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | Marketscreener.com | 11 hours ago |
|
| 34 | Y-mAbs Announces Second Quarter Financial Results and Recent Corporate Developments | GlobeNewswire | 1 day ago |
|
| 35 | Video footages, confessions expose Baloch 'missing persons' claim | The Express Tribune | 21 days ago |
|
| 36 | Kodiak Sciences Announces Second Quarter 2022 Financial Results and Recent Business Highlights | Yahoo Finance | 11 hours ago |
|
| 37 | Tagging a Memory as Positive or Negative | Psychology Today | 6 days ago |
|
| 38 | FDA Updates for Week of July 11, 2022 | Managed Healthcare Executive | 25 days ago |
|
| 39 | Pr Secy Jal Shakti reviews implementation of JJM, other schemes at Bla | Kashmir Images | 3 days ago |
|
| 40 | Five BLA terrorists shot dead in Ziarat operation | The Nation | 25 days ago |
|
| 41 | Wordle game help: 5-letter words starting with 'BLA' | Dot Esports | 29 days ago |
|
| 42 | Provention Bio Reports Second Quarter 2022 Financial Results and Provides Business Update | Yahoo Finance | 6 days ago |
|
| 43 | Sarepta Therapeutics Rallies on BLA Submission Intent By Investing.com | Investing.com India | 12 days ago |
|
| 44 | Balochistan Facing Vilest Humanitarian Crisis In A Generation – Greek City Times | GreekCityTimes.com | 3 days ago |
|
| 45 | FDA Updates for Week of Aug. 1, 2022 | Managed Healthcare Executive | 4 days ago |
|
| 46 | FDA Action Alert: Coherus, Sanofi and Regeneron, Acadia, Myovant and Pfizer | BioSpace | 9 days ago |
|
| 47 | Mangaluru: Bethany convent celebrates BLA day | Daijiworld.com | 14 days ago |
|
| 48 | Udhm-Bla Rail Link: 94% deck laid over World’s Highest Railway Bridge on Chenab River | The Northlines | 9 days ago |
|
| 49 | The ultimate fate of a star shredded by a black hole | EurekAlert | 1 month ago |
|
| 50 | ECI extends date for publication of J&K's electoral rolls | Brighter Kashmir | 13 hours ago |
|
| 51 | Delegation of PC workers from District Bla calls on Sajad Lone | Kashmir Images | 13 days ago |
|
| 52 | Sesen Bio Reports Second Quarter 2022 Financial Results and Business Update | BioSpace | 2 days ago |
|
| 53 | Balochistan: Stall selling Pakistani flags targeted, gas pipeline blown up | Balochwarna News | 5 days ago |
|
| 54 | FDA Update for Week of July 25 | Managed Healthcare Executive | 11 days ago |
|
| 55 | Pakistan military cantonment attacked in Quetta – Balochwarna News | Balochwarna News | 11 days ago |
|
| 56 | Sequence Analysis, Antibiogram Profile, Virulence and Antibiotic Resis | IDR | Dove Medical Press | 1 day ago |
|
| 57 | GD Goenka, DIS Sgr, DPS Bla achieve 100% results in CBSE exams | Greater Kashmir | 18 days ago |
|
| 58 | BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance | Investor Relations : BioMarin | 6 days ago |
|
| 59 | What's On Nightlife Awards 2022: Here are the nominees... | What's On | 2 days ago |
|
| 60 | ADC Therapeutics SA (ADCT) Q2 2022 Earnings Call Transcript | The Motley Fool | 4 hours ago |
|
| 61 | Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab | UCB | 2 months ago |
|
| 62 | FDA seeks additional information in BLA for ONS-5010 | Ophthalmology Times | 2 months ago |
|
| 63 | FDA Accepts BLA Resubmission for DAXI Injections | Dermatology Times | 4 months ago |
|
| 64 | FDA Accepts BLA Resubmission for Toripalimab in Advanced Nasopharyngeal Carcinoma | OncLive | 1 month ago |
|
| 65 | IntelBrief: Balochistan Liberation Army (BLA) Presents Unique Threat to Pakistan | The Soufan Center | 3 months ago |
|
| 66 | Rolling Submission of BLA to FDA Completed for Omidubicel in Blood Cancers Requiring Transplant | OncLive | 2 months ago |
|
| 67 | Positive FDA Feedback Supports BLA Submission for Lifileucel in Melanoma | OncLive | 4 months ago |
|
| 68 | With Positive Data, Checkpoint Looks to Add Second Indication to BLA | BioSpace | 2 months ago |
|
| 69 | #ASCO22: Merus looks to beat Elevation to NRG1+ summit as BLA filing approaches | Endpoints News | 2 months ago |
|
| 70 | Outlook Therapeutics Confirms Status of Biologics License Application (BLA) Submission for ONS-5010 | Yahoo Finance | 2 months ago |
|
| 71 | Epcoritamab BLA To Be Submitted to FDA for Relapsed/Refractory LBCL | Cancer Network | 1 month ago |
|
| 72 | Factbox: Who are the Pakistan separatists behind attack on Chinese citizens? | Reuters.com | 4 months ago |
|
| 73 | FDA Accepts Alvotech's BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira® | Business Wire | 5 months ago |
|
| 74 | Seres Pivotal Success And BLA Filing A Boost To Microbiome Modulator Field | Scrip | 2 months ago |
|
| 75 | FDA Accepts BLA of Mirvetuximab Soravtansine Under Priority Review in FRα-high Platinum-Resistant Ovarian Cancer | Cancer Network | 3 months ago |
|
| 76 | TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS | Yahoo Finance | 2 months ago |
|
| 77 | Adaptimmune: Underappreciated Biotech With BLA Filing Q4 Of 2022 (NASDAQ:ADAP) | Seeking Alpha | 1 month ago |
|
| 78 | FDA Accepts BLA for Tremelimumab With Durvalumab for Priority Review | Pharmacy Times | 4 months ago |
|
| 79 | Adaptimmune Therapeutics Stock Ahead Of Anticipated BLA (NASDAQ:ADAP) | Seeking Alpha | 2 months ago |
|
| 80 | ImmunityBio: Shifting Gears After Long-Awaited BLA Submission (NASDAQ:IBRX) | Seeking Alpha | 2 months ago |
|
| 81 | Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim | Yahoo Finance | 4 months ago |
|
| 82 | AEGLEA BIOTHERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) | Marketscreener.com | 6 days ago |
|
| 83 | ImmunityBio Provides Updated Status of Biologics License Application (BLA) for VesAnktiva Plus BCG for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ | Business Wire | 4 months ago |
|
| 84 | Biosimilar Pegfilgrastim BLA Accepted by FDA for Neutropenia During Chemotherapy | Cancer Network | 2 months ago |
|
| 85 | BLA Submitted for Mirvetuximab Soravtansine in Ovarian Cancer | Pharmacy Times | 4 months ago |
|
| 86 | Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q2 2022 Results | Earnings Call Transcript | 7 days ago |
|
| 87 | Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection | Nature.com | 9 days ago |
|
| 88 | FDA extends BLA review of Regeneron's Covid-19 therapy | Pharmaceutical Technology | 4 months ago |
|
| 89 | 18 By October Register As Voter, Electoral Office Issues Notice | Kashmir Life | 14 hours ago |
|
| 90 | PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab | Business Wire | 3 months ago |
|
| 91 | Aeglea Stumbles in First BLA Attempt as FDA Issues RTF | BioSpace | 2 months ago |
|
| 92 | Lilly UC Treatment Holds Edge in Maintenance Study, Setting Up BLA | BioSpace | 8 months ago |
|
| 93 | Junshi Biosciences and Coherus Receive Complete Response Letter from U.S. FDA for Toripalimab BLA | GlobeNewswire | 3 months ago |
|
| 94 | Ublituximab/Umbralisib BLA/sNDA in CLL and SLL Voluntarily Withdrawn | OncLive | 4 months ago |
|
| 95 | Talaris is Rapidly Expanding as it Speeds Toward a First BLA | BioSpace | 8 months ago |
|
| 96 | FDA Approves Moderna's SPIKEVAX BLA | Contract Pharma | 6 months ago |
|
| 97 | Agenus Withdraws BLA for Balstilimab in Metastatic Cervical Cancer | OncLive | 10 months ago |
|
| 98 | Omburtamab BLA for Pediatric Metastatic Neuroblastoma Resubmitted to FDA | OncLive | 4 months ago |
|
| 99 | Humacyte’s Engineered Blood Vessels in Final Push Toward BLA | BioSpace | 3 months ago |
|
| 100 | Eisai Completes Rolling BLA Submission for Lecanemab to Treat MCI, Alzheimer Disease | Neurology Live | 3 months ago |
|